Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Atherosclerosis Supplements

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosissup.2010.03.004PMID 20427244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic aspects of pancreatitis.

  2010cited by this paper
• Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects

  2010cited by this paper
• AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

  2009cited by this paper
• Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

  2009cited by this paper
• Chronic pancreatitis: genetics and pathogenesis.

  2009cited by this paper
• Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients.

  2008cited by this paper
• Acute pancreatitis.

  2008cited by this paper
• Investigation and management of hypertriglyceridaemia

  2008cited by this paper
• Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass.

  2007cited by this paper
• The Pancreas Misled: Signals to Pancreatitis

  2007cited by this paper
• Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study.

  2006cited by this paper
• Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study

  2006cited by this paper
• AAV1-LPL(S447X) gene therapy reduces hypertriglyceridemia in apoE2 knock in mice.

  2006cited by this paper
• Recent developments in gene transfer: risk and ethics

  2005cited by this paper
• Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application

  2005cited by this paper
• Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.

  2005cited by this paper
• Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 Mutations

  2004cited by this paper
• Caloric and vitamin distribution by LpL 4. Synthesis and processing of lipases 5. Lipoproteins and regulation of the lipolysis reaction 6. Apolipoproteins 7. Non-enzymatic actions of lipoprotein lipase 8. Structure-function analysis of lipoprotein lipase 9.Genetic variation in lipoprotein lipase 10.

  2002cited by this paper
• Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study1

  2002cited by this paper
• Lipoprotein lipase: physiology, biochemistry, and molecular biology.

  2001cited by this paper
• Chronic pancreatitis: diagnosis, classification, and new genetic developments.

  2001cited by this paper
• RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1

  2001cited by this paper
• Biostatistical Methods: The Assessment of Relative Risks

  2000cited by this paper
• Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease A Meta-Analysis

  1999cited by this paper
• Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.

  1999cited by this paper
• The familial chylomicronemia syndrome.

  1998cited by this paper
• Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

  1998cited by this paper
• Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.

  1996cited by this paper
• Clinical assessment of hyperlipidemic pancreatitis.

  1995cited by this paper
• Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat.

  1993cited by this paper
• Chylomicronemia syndrome.

  1992cited by this paper
• Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population.

  1989cited by this paper
• The Metabolic basis of inherited disease

  1989cited by this paper
• On The Quantitative Definition of Risk

  1981cited by this paper

• Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia

  2025cites this paper
• Combination of miRNA148a-3p binding sites and C5-12 promoter in rAAV vector synergistically reduces antigen presentation and transgene immunity.

  2025cites this paper
• Olezarsen and Beyond: Emerging Targeted Treatments for Familial Chylomicronemia Syndrome and Related Triglyceride Disorders

  2025cites this paper
• A Case Study of a Rare Disease (Fructosemia) Diagnosed in a Patient with Abdominal Pain

  2024cites this paper
• A unified model for regulating lipoprotein lipase activity

  2024cites this paper
• Transitional Medicine of Intractable Primary Dyslipidemias in Japan

  2024cites this paper
• Dyslipidemia - the known unknown.

  2023cites this paper
• Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy

  2023cites this paper
• Posicionamento Brasileiro sobre Síndrome da Quilomicronemia Familiar – 2023

  2023cites this paper
• A novel homozygous nonsense variant of LMF1 in pregnancy-induced hypertriglyceridemia with acute pancreatitis.

  2023cites this paper
• Viral Vectors in Gene Replacement Therapy

  2023cites this paper
• Hypertriglyceridaemia: an update

  2022cites this paper
• Directed Evolution of AAV Targeting Primate Retina by Intravitreal Injection Identifies R100, a Variant Demonstrating Robust Gene Delivery and Therapeutic Efficacy in Non-Human Primates

  2021cites this paper
• Current Diagnosis and Management of Primary Chylomicronemia

  2021cites this paper
• Severe acquired hypertriglyceridemia following COVID-19

  2021cites this paper
• Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis

  2021cites this paper
• Hypertriglyceridemic pancreatitis.

  2020cites this paper
• DDDT_A_224771 2623..2636

  2020cites this paper
• Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy

  2020cites this paper
• Hypertriglycéridémies pures

  2020cites this paper
• Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice.

  2019cites this paper
• Hypertriglyceridemias and Their Treatment

  2019cites this paper
• CRISPR-mediated gene editing for the surgeon scientist.

  2019cites this paper
• Neues zu Relevanz und Behandlung des Chylomikronämie-Syndroms

  2019cites this paper
• A Genome-Wide Knock-Out Screen Identifies Novel Host Cell Entry Factor Requirements for Divergent Adeno-Associated Virus Serotypes

  2019cites this paper
• Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions

  2018cites this paper
• Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management

  2018influential citation
• Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

  2018cites this paper
• Very Severe Hypertriglyceridemia-Casre Report with General Considerations

  2018cites this paper
• Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury

  2018cites this paper
• Evaluating the impact of peer support and connection on the quality of life of patients with familial chylomicronemia syndrome

  2018cites this paper
• Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome

  2018cites this paper
• Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia

  2018cites this paper
• The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study

  2018cites this paper
• High-Throughput Dissection of AAV-Host Interactions: The Fast and the Curious.

  2018cites this paper
• Chylomicronemia Syndrome: Very Severe Hypertriglyceridemia and Acute Pancreatitis

  2018cites this paper
• Identifying suspected familial chylomicronemia syndrome

  2018cites this paper
• An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor

  2018cites this paper
• Polymers in the Delivery of siRNA for the Treatment of Virus Infections

  2017cites this paper
• Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.

  2017cites this paper
• Protocol for efficient generation and characterization of adeno-associated viral (AAV) vectors.

  2017cites this paper
• Clinical Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase 1 Inhibitor

  2017cites this paper
• Highly efficient Cas9 mediated transcriptional programming and delivery via Adeno-Associated Virus

  2017cites this paper
• Preventive, Diagnostic and Therapeutic Applications of Baculovirus Expression Vector System

  2017cites this paper
• Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors.

  2017cites this paper
• Polymers in the Delivery of siRNA for the Treatment of Virus Infections

  2017cites this paper
• The burden of familial chylomicronemia syndrome from the patients’ perspective

  2017cites this paper
• AAV Vector-Based Gene Therapy, Progress and Current Challenges

  2017cites this paper
• Advances in Hypercholesterolemia

  2017cites this paper
• Diagnostic algorithm for familial chylomicronemia syndrome.

  2017cites this paper
• Protocol for Efficient Generation and Characterization of Adeno-Associated Viral Vectors

  2017cites this paper
• The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.

  2017cites this paper
• The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study

  2017cites this paper
• A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons.

  2016cites this paper
• Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.

  2016cites this paper
• Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.

  2016cites this paper
• Next stop for the CRISPR revolution: RNA‐guided epigenetic regulators

  2016cites this paper
• Extracting structural and functional features of widely distributed biological circuits with single cell resolution via tissue clearing and delivery vectors.

  2016cites this paper
• MOLECULAR APPROACHES FOR CONTROLLING RNA STABILITY

  2016cites this paper
• In vivo genome editing using Staphylococcus aureus Cas9

  2015cites this paper
• Gene Replacement Therapy for Genetic Hepatocellular Jaundice

  2015cites this paper
• AAV-Nrf2 Mediated Rescue of Oxidative Stress in Mouse Models

  2015influential citation
• Caractérisation du profil d'expression et des potentielles cibles off-targets d'un U7snRNA optimisé pour le traitement par saut d'exon de la Dystrophie Musculaire de Duchenne

  2015cites this paper
• Emergent triglyceride-lowering therapy for hypertriglyceridemic pancreatitis.

  2015cites this paper
• Alipogene Tiparvovec: A Review of Its Use in Adults with Familial Lipoprotein Lipase Deficiency

  2015influential citation
• Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain

  2015cites this paper
• Viral Vectors for Gene Therapy: Translational and Clinical Outlook.

  2015cites this paper
• Damaging the Integrated HIV Proviral DNA with TALENs

  2015cites this paper
• Investigation and application of novel adeno-associated viral vectors for Cystic Fibrosis gene therapy

  2015cites this paper
• Breakthroughs and barriers in clinical gene therapy

  2015cites this paper
• Gene therapy for arthritis: progress towards a clinical trial

  2015cites this paper
• Conception d'un système de veille et de consolidation des développements cliniques avancés en matière de thérapie génique

  2015cites this paper
• The development of cationic polymers for non-viral gene delivery system

  2015cites this paper
• Targeted Molecular Therapeutics for Atherosclerosis

  2015cites this paper
• Identification de biomarqueurs de risque à la pancréatite aigüe récurrente dans l’hyperchylomicronémie familiale

  2015cites this paper
• Alipogene Tiparvovec: Gene Therapy for Familial Lipoprotein Lipase Deficiency

  2015cites this paper
• Gene Therapy for Parkinson’s Disease: AAV5-Mediated Delivery of Glial Cell Line-Derived Neurotrophic Factor (GDNF)

  2015cites this paper
• An update on gene therapy for the treatment of lipoprotein lipase deficiency

  2014cites this paper
• Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside

  2014cites this paper
• From fetal physiology to gene therapy: it all started in Loma Linda.

  2014cites this paper
• Engineering adeno-associated viruses for clinical gene therapy

  2014cites this paper
• The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

  2014cites this paper
• Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates

  2014cites this paper
• Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency

  2014influential citation
• Recommendations for severe hypertriglyceridemia treatment, are there new strategies?

  2014cites this paper
• Postprandial lipemia as a cardiometabolic risk factor

  2014cites this paper
• Emerging Therapeutic Approaches to Treat Dyslipidemia

  2014cites this paper
• AAV shuffles to the liver: commentary on Lisowski et al.

  2014cites this paper
• Recent advances in pharmacotherapy for hypertriglyceridemia.

  2014cites this paper
• Review article Postprandial lipemia as a cardiometabolic risk factor

  2014cites this paper
• of FVII at levels that protect against fatal spontaneous hemorrhage AAV-mediated gene transfer in the perinatal period results in expression

  2014cites this paper
• Obesity Diabetes mellitus Oral estrogens ; selective estrogen receptor modulators Physical inactivity Polycystic ovary syndrome Beta-blockers Diet high in fat and simple sugars Hypothyroidism Thiazides Excessive alcohol consumption Nephrotic syndrome , chronic renal disease Atypical antipsychotics C

  2014cites this paper
• Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery

  2013cites this paper
• Lessons Learned from the Clinical Development and Market Authorization of Glybera

  2013influential citation
• HDL, Atherosclerosis, and Emerging Therapies

  2013cites this paper
• Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans

  2013cites this paper
• Hypertriglyceridemia

  2013cites this paper
• The State of the Art and Future of Gene Medicines

  2013cites this paper
• Medical resource use and costs associated with chylomicronemia

  2013cites this paper
• Lipoprotein and Lipid Metabolism

  2013cites this paper